PPD Stock Price, Chart, Stats & News

PPD, Inc.
Save
–
Market cap
–
Current P/E
–
Forward P/E
PPD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 38.42% |
Operating margin | 10.88% |
Pretax margin | 3.68% |
Net margin | 3.28% |
Effective tax rate | 10.90% |
ROA | 2.44% |
ROE | -8.92% |
D/E | -5.96x |
Interest coverage ratio | 2.35x |
PPD valuation
P/E | – |
P/S | – |
P/B | -21.96x |
P/CF | 65.22x |
P/FCF | – |
P/OCF | 65.22x |
PEG | 1.07x |
EV multiple | -5.39x |
About
PPD, Inc. delivers a full spectrum of drug development services internationally, primarily catering to the biopharmaceutical industry. The company structures its operations across two core divisions: Clinical Development Services and Laboratory Services. Under its Clinical Development arm, PPD provides a diverse range of support, including initial product strategy and advisory services, early-stage development, end-to-end management of clinical trials from Phase II through Phase IV, techniques for accelerated patient recruitment, assistance with pre- and post-market approval processes, and various medical communication solutions.
Similar securities
Based on sector and market capitalization
Report issue











